5,094 reports of this reaction
3.5% of all PEGFILGRASTIM reports
#6 most reported adverse reaction
DEVICE ISSUE is the #6 most commonly reported adverse reaction for PEGFILGRASTIM, manufactured by Amgen, Inc. There are 5,094 FDA adverse event reports linking PEGFILGRASTIM to DEVICE ISSUE. This represents approximately 3.5% of all 146,341 adverse event reports for this drug.
Patients taking PEGFILGRASTIM who experience device issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEVICE ISSUE is moderately reported among PEGFILGRASTIM users, representing a notable but not dominant share of adverse events.
In addition to device issue, the following adverse reactions have been reported for PEGFILGRASTIM:
The following drugs have also been linked to device issue in FDA adverse event reports:
DEVICE ISSUE has been reported as an adverse event in 5,094 FDA reports for PEGFILGRASTIM. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEVICE ISSUE accounts for approximately 3.5% of all adverse event reports for PEGFILGRASTIM, making it a notable side effect.
If you experience device issue while taking PEGFILGRASTIM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.